FDA News

FDA approves generic Narcan nasal spray

April 22, 2019
The FDA recently approved the first generic nasal spray of the opioid overdose antidote Narcan for use in a community setting without medical…

Most injection drug users in 8 US cities have been infected with HCV

April 22, 2019
More than 55% of people who inject drugs, or PWID, in eight United States cities were found to have been infected with hepatitis C virus, including…
Meeting NewsVideo

VIDEO: Givosiran may ‘transform’ lives of patients with acute hepatic porphyria

April 20, 2019
VIENNA — In this exclusive video from the 2019 International Liver Congress, Akin Akinc, PhD, of Alnylam Pharmaceuticals, discusses results of…
Meeting NewsVideo

VIDEO: Children ‘must not be left behind’ in the fight for hepatitis elimination

April 18, 2019
CHICAGO — In this exclusive video from the International Liver Congress 2019, Marc Bulterys, MD, PhD, team leader of the Global Hepatitis…
Meeting News

Generalists, specialists must work together to ‘narrow gaps’ in HCV care cascade

April 18, 2019
VIENNA — In the face of the remaining gaps in the hepatitis C care cascade, timely screening, monitoring and linkage to care by general…
Meeting News

3 ways to reduce burnout

April 18, 2019
PHILADELPHIA — Data indicate that rates of physician burnout are declining, but it remains a significant issue for clinicians, a speaker at the…
Meeting NewsVideo

VIDEO: Transparency improves patient care, builds just culture

April 17, 2019
PHILADELPHIA — While strategies such as public reporting, transparency and using clinical decision support and electronic health records are…
Meeting News

Prevalence of alcoholic cirrhosis rising in North American men

April 17, 2019
VIENNA — Researchers reported an increasing prevalence of alcoholic cirrhosis in a large representative Canadian population, especially among…
Meeting NewsVideo

VIDEO: Seladelpar met phase 2 alkaline phosphatase endpoint in PBC

April 17, 2019
VIENNA — In this exclusive video from the International Liver Congress 2019, Marlyn J. Mayo, MD, from The University of Texas, presents…
Meeting News

Epclusa achieves best SVR rates in patients with HCV genotype 3

April 16, 2019
VIENNA — Patients with hepatitis C genotype 3 and compensated cirrhosis had higher rates of sustained virologic response after treatment with…
Meeting NewsVideo

VIDEO: Plasma shows impact of Middle Eastern diet on microbiome

April 16, 2019
VIENNA — In this exclusive video from the International Liver Congress 2019, Bajaj S. Jasmohan, MD, from the Virginia Commonwealth University…
In the Journals

ACP recommends ways to strengthen ACA

April 15, 2019
In a new position paper published in Annals of Internal Medicine, the ACP offers seven comprehensive recommendations to improve the Patient…
Meeting News

Things physicians need to know about medical marijuana

April 15, 2019
PHILADELPHIA — More than 150 years after the first medicinal use of marijuana was recorded, and there is still not an abundance of research…
Meeting News

Core protein inhibitor, nuc combination shows promise in HBV

April 13, 2019
VIENNA — A combination of a core protein inhibitor and nucleos(t)ide analogue therapy brought hepatitis B virus RNA and DNA below levels of…
Meeting News

Elafibranor shows anticholestatic effect in PBC

April 13, 2019
VIENNA — When patients do not fully respond to ursodeoxycholic acid, a new peroxisome proliferator-activated receptor alpha and delta agonist…
Meeting News

How to engage in ‘curbside consultations’

April 13, 2019
PHILADELPHIA — Curbside consultations are “desirable and well-accepted when used appropriately” according to a discussion held at…
Meeting News

Emricasan reduces portal pressure in cirrhosis despite missing endpoint

April 13, 2019
VIENNA — Emricasan missed its primary endpoint of hepatic venous pressure gradient reduction in all patients with nonalcoholic…
Meeting NewsVideo

VIDEO: Physicians must nurture the engaged patient

April 13, 2019
VIENNA — In this exclusive video from the International Liver Congress 2019, Wayne Eskridge, founder and CEO of the Fatty Liver Foundation…
Meeting News

Givosiran offers hope for acute hepatic porphyria recurrent attacks

April 13, 2019
VIENNA — An “exciting, novel RNAi therapy” significantly lowered acute hepatic porphyria recurrent attacks, according to data…
Meeting News

FMT capsules treat encephalopathy: ‘The way to the brain is through the gut’

April 13, 2019
VIENNA — Fecal microbiota transplant, delivered via capsule, lessened hospitalizations for patients with hepatic encephalopathy while improving…